Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-05 Sale | 2024-06-07 4:05 pm | Adicet Bio Inc. | ACET | Kauffman Michael Director | 5,900 | $1.43 | $8,437 | 32,300 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 3:18 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Director | 12,452 | $10.24 | $127,477 | 1,638,888 (Indirect Direct) | View |
| 2022-02-17 Sale | 2022-02-22 4:14 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Director | 18,167 | $12.12 | $220,246 | 1,603,340 (Indirect Direct) | View |
| 2022-02-07 Sale | 2022-02-09 5:24 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Director | 13,471 | $9.862 | $132,851 | 1,621,507 (Indirect Direct) | View |
| 2022-01-03 Sale | 2022-01-05 6:51 pm | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 5,000 | $16.45 | $82,250 | 67,586 (Direct) | View |
| 2021-03-18 Sale | 2021-03-23 07:48 am | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 4,000 | $12.39 | $49,553 | 1,634,978 (Indirect Direct) | View |
| 2021-02-18 Sale | 2021-02-22 8:09 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 18,990 | $14.83 | $281,644 | 1,351,578 (Indirect Direct) | View |
| 2021-02-11 Sale | 2021-02-17 6:44 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 13,243 | $15.52 | $205,518 | 1,457,768 (Indirect Direct) | View |
| 2020-10-12 Sale | 2020-10-14 5:56 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $14.89 | $111,683 | 1,311,611 (Indirect Direct) | View |
| 2020-08-17 Sale | 2020-08-18 6:07 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 1,477 | $15 | $22,155 | 1,317,687 (Indirect Direct) | View |
| 2020-07-15 Sale | 2020-07-17 4:26 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $19.43 | $145,723 | 1,313,035 (Indirect Direct) | View |
| 2020-07-09 Sale | 2020-07-13 6:45 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $19.27 | $289,026 | 2,022,975 (Indirect Direct) | View |
| 2020-06-22 Sale | 2020-06-24 4:07 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $20 | $150,000 | 1,320,535 (Indirect Direct) | View |
| 2020-06-15 Sale | 2020-06-17 4:07 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $16.37 | $122,779 | 1,328,035 (Indirect Direct) | View |
| 2020-06-09 Sale | 2020-06-11 4:39 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $18.31 | $274,690 | 2,037,975 (Indirect Direct) | View |
| 2020-05-15 Sale | 2020-05-19 5:36 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $19.32 | $289,841 | 1,319,825 (Indirect Direct) | View |
| 2020-05-07 Sale | 2020-05-11 4:19 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $19.63 | $294,414 | 2,052,975 (Indirect Direct) | View |
| 2020-04-08 Sale | 2020-04-10 5:09 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 20,000 | $19.63 | $392,519 | 2,067,975 (Indirect Direct) | View |
| 2020-03-09 Sale | 2020-03-11 7:07 pm | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 20,000 | $22.37 | $447,381 | 2,087,975 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-21 Option Award | 2024-08-23 4:05 pm | N/A 2031-11-16 | Adicet Bio Inc. | ACET | Kauffman Michael Director | 81,900 | $0 | 81,900 (Direct) | View |
| 2024-08-21 Disposition | 2024-08-23 4:05 pm | N/A 2031-11-16 | Adicet Bio Inc. | ACET | Kauffman Michael Director | 81,900 | $0 | 81,900 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-21 4:20 pm | N/A 2034-06-19 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 8:30 pm | N/A 2034-06-18 | Verastem Inc. | VSTM | Kauffman Michael Director | 20,833 | $0 | 21,383 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:05 pm | N/A 2034-06-04 | Adicet Bio Inc. | ACET | Kauffman Michael Director | 32,300 | $0 | 32,300 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-13 6:07 pm | N/A 2034-03-11 | Verastem Inc. | VSTM | Kauffman Michael Director | 16,078 | $0 | 16,078 (Direct) | View |
| 2024-03-11 Disposition | 2024-03-13 6:07 pm | N/A 2024-06-10 | Verastem Inc. | VSTM | Kauffman Michael Director | 16,078 | $0 | 16,078 (Direct) | View |
| 2023-08-14 Option Award | 2023-08-16 6:07 pm | N/A 2031-11-16 | Adicet Bio Inc. | ACET | Kauffman Michael Director | 81,900 | $0 | 81,900 (Direct) | View |
| 2023-08-14 Disposition | 2023-08-16 6:07 pm | N/A 2031-11-16 | Adicet Bio Inc. | ACET | Kauffman Michael Director | 81,900 | $0 | 81,900 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 5:04 pm | N/A 2029-06-24 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 69,792 | $0 | 69,792 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 5:04 pm | N/A 2029-06-24 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 69,792 | $0 | 69,792 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:36 pm | N/A 2033-06-14 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 5:48 pm | N/A 2033-05-31 | Adicet Bio Inc. | ACET | Kauffman Michael Director | 32,300 | $0 | 32,300 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-16 4:34 pm | N/A 2033-05-15 | Verastem Inc. | VSTM | Kauffman Michael Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-05-12 Option Award(A) | 2022-12-20 4:07 pm | N/A 2032-05-12 | Verastem Inc. | VSTM | Kauffman Michael Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:10 pm | N/A 2032-06-22 | Verastem Inc. | VSTM | Kauffman Michael Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 6:04 pm | N/A 2032-06-15 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:38 pm | N/A 2032-06-01 | Adicet Bio Inc. | ACET | Kauffman Michael Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 3:18 pm | N/A 2032-02-27 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Director | 48,000 | $0 | 1,638,888 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 6:51 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 5,000 | $5.91 | 67,586 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 6:51 pm | N/A 2028-04-15 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 5,000 | $0 | 67,586 (Direct) | View |
| 2021-11-17 Option Award | 2021-11-18 07:13 am | N/A 2031-11-16 | Adicet Bio Inc. | ACET | Kauffman Michael Director | 37,000 | $0 | 37,000 (Direct) | View |
| 2021-06-28 Option Award | 2021-06-30 6:47 pm | N/A 2031-06-27 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2021-06-28 Option Award | 2021-06-30 1:56 pm | N/A 2031-06-28 | Verastem Inc. | VSTM | Kauffman Michael Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 8:09 pm | N/A 2031-02-24 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 364,200 | $0 | 1,945,978 (Direct) | View |
| 2021-02-15 Exercise | 2021-02-17 6:44 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 43,600 | $0 | 1,457,768 (Direct) | View |
| 2021-02-05 Exercise | 2021-02-09 8:28 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 28,600 | $0 | 1,426,011 (Direct) | View |
| 2020-10-12 Exercise | 2020-10-14 5:56 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $0.033 | 1,311,611 (Indirect) | View |
| 2020-10-12 Exercise | 2020-10-14 5:56 pm | N/A 2020-10-31 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $0 | 1,311,611 (Indirect) | View |
| 2020-08-17 Exercise | 2020-08-18 6:07 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 1,477 | $0.033 | 1,317,687 (Indirect) | View |
| 2020-08-17 Exercise | 2020-08-18 6:07 pm | N/A 2020-10-31 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 1,477 | $0 | 1,317,687 (Indirect) | View |
| 2020-07-15 Exercise | 2020-07-17 4:26 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $0.033 | 1,313,035 (Indirect) | View |
| 2020-07-15 Exercise | 2020-07-17 4:26 pm | N/A 2020-10-31 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $0 | 1,313,035 (Indirect) | View |
| 2020-07-10 Exercise | 2020-07-13 6:45 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $4.752 | 2,022,975 (Direct) | View |
| 2020-07-10 Exercise | 2020-07-13 6:45 pm | N/A 2023-09-02 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $0 | 2,022,975 (Direct) | View |
| 2020-06-24 Option Award | 2020-06-26 5:19 pm | N/A 2030-06-23 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 8,896 | $0 | 8,896 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-24 4:07 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $0.033 | 1,320,535 (Indirect) | View |
| 2020-06-22 Exercise | 2020-06-24 4:07 pm | N/A 2020-10-31 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $0 | 1,320,535 (Indirect) | View |
| 2020-06-16 Option Award | 2020-06-18 6:00 pm | N/A 2030-06-16 | Verastem Inc. | VSTM | Kauffman Michael Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-06-15 Exercise | 2020-06-17 4:07 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $0.033 | 1,328,035 (Indirect) | View |
| 2020-06-15 Exercise | 2020-06-17 4:07 pm | N/A 2020-10-31 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $0 | 1,328,035 (Indirect) | View |
| 2020-06-10 Exercise | 2020-06-11 4:39 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $4.752 | 2,037,975 (Direct) | View |
| 2020-06-10 Exercise | 2020-06-11 4:39 pm | N/A 2023-09-02 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $0 | 2,037,975 (Direct) | View |
| 2020-05-15 Exercise | 2020-05-19 5:36 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $0.033 | 1,319,825 (Indirect) | View |
| 2020-05-15 Exercise | 2020-05-19 5:36 pm | N/A 2020-10-21 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $0 | 1,319,825 (Indirect) | View |
| 2020-05-07 Exercise | 2020-05-11 4:19 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 7,500 | $4.752 | 2,052,975 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-11 4:19 pm | N/A 2023-09-02 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 15,000 | $0 | 2,052,975 (Direct) | View |
| 2020-04-09 Exercise | 2020-04-10 5:09 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 20,000 | $4.752 | 2,067,975 (Direct) | View |
| 2020-04-09 Exercise | 2020-04-10 5:09 pm | N/A 2023-09-02 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 20,000 | $0 | 2,067,975 (Direct) | View |
| 2020-03-10 Exercise | 2020-03-11 7:07 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 20,000 | $4.752 | 2,087,975 (Direct) | View |
| 2020-03-10 Exercise | 2020-03-11 7:07 pm | N/A 2023-09-02 | Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer | 20,000 | $0 | 2,087,975 (Direct) | View |